Cedrus LLC Becton Dickinson & CO Transaction History

Cedrus LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$232.24 - $267.23 $232 - $267	1 Added 0.11%	871 $212 Million
Q3 2023 Jan 24, 2024	SELL	$254.9 - $283.59 $24,215 - $26,941	-95 Reduced 9.84%	870 $225 Million
Q2 2023 Jan 24, 2024	BUY	$238.39 - $265.32 $476 - $530	2 Added 0.21%	965 $255 Million
Q1 2023 Jan 24, 2024	BUY	$229.71 - $259.35 $221,210 - $249,754	963 New	963 $238 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

Stay updated on Cedrus LLC with notifications on news.